Navigation Links
Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
Date:8/30/2010

ntiviral drug regimens.
  • Bioterror and Pandemic Threats:  Represents the most advanced broad-spectrum strategy to address untreatable bioterror and emerging pandemic threats.

  • The Hemopurifier® is an expansive multi-patented platform technology whose mechanism of action can be leveraged to provide therapeutic, diagnostic, and biomarker discovery solutions. As a therapeutic, the Hemopurifier® is a single-use disposable cartridge designed for implementation within the established infrastructure of dialysis machines and other blood circulatory pumps already located in hospitals and clinics worldwide.

    In design, our Hemopurifier® is a selective filtration device containing affinity agents that tightly bind to high-mannose structures unique to the surface of exosomes produced by cancer and glycoproteins residing on the envelope of viruses. These agents are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.

    Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI), is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.

    Certain of the
    '/>"/>

    SOURCE Aethlon Medical, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
    2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
    3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
    4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
    5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
    6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
    7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    8. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
    9. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
    10. Globus Medical Raises $110 Million in Series E Financing Round
    11. Quark Pharmaceuticals Appoints New Chief Medical Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/28/2015)... , May 28, 2015  The recent ... health plans and employer groups scrambling to identify ... a major managed care plan, retail pharmacy chain, ... Healthcare,s $13.3 billion purchase of Catamaran, Rite Aid,s ... announcement to purchase Omni-Care for $10 billion are ...
    (Date:5/28/2015)... , May 28, 2015 The ... the Commission,s antitrust suit charging Cephalon, Inc. with ... drug Provigil. The settlement ensures that Teva Pharmaceutical ... make a total of $1.2 billion available to ... who overpaid because of Cephalon,s illegal conduct.  ...
    (Date:5/28/2015)... May 28, 2015 Lungpacer Medical, Inc., ... phrenic-nerve-pacing system announced today that it will be ... on Thursday, June 4, 2015 in New York ... a.m. Eastern Time.   About Lungpacer ... preclinical stage medical device company pioneering the development ...
    Breaking Medicine Technology:Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 2Citizens Rx Addresses Recent PBM Consolidation and Rising Pharmacy Costs 3FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 2FTC Settlement of Cephalon Pay for Delay Case Ensures $1.2 Billion in Ill-Gotten Gains Relinquished; Refunds Will Go To Purchasers Affected By Anticompetitive Tactics 3
    (Date:5/28/2015)... AMVETS National Executive Director Stewart Hickey has been ... by Congress to examine how to best deliver health ... commission by Mitch McConnell, majority leader of the U.S. ... voting members on the panel, which was established by ... The goal of the commission is to examine how ...
    (Date:5/28/2015)... 2015 The Clinical Data Interchange ... the International Organization for Standardization (ISO) now recognizes ... Model version 3.2 as a published, Final International ... healthcare. This standard, which had previously passed through ... unanimously approved on 24 April for publication by ...
    (Date:5/28/2015)... On Sunday, June 21, 2015, Colorado residents will participate ... the strength, passion and endurance of those facing Alzheimer’s ... this sunrise-to-sunset event symbolizes the challenging journey of those ... funds and awareness to advance the care, support and ... encouraged to create their own experience as they fundraise ...
    (Date:5/28/2015)... Calif. (PRWEB) May 28, 2015 Restricting ... prevent firearm violence, but policies that more clearly define ... to a review of existing research and public policies ... The analysis, published online April 30 in the peer-reviewed ... drinking and other forms of alcohol misuse in association ...
    (Date:5/28/2015)... May 28, 2015 Three years ago, Dr. ... for his Shore Vascular & Vein Center! Dr. ... system. It is his mission to provide the highest ... , Dr. Jeffrey Gosin is Board Certified in ... University of Pennsylvania and Jefferson Medical College. He completed a ...
    Breaking Medicine News(10 mins):Health News:AMVETS Executive Director Stewart Hickey Appointed to Congressional Commission on Care 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 2Health News:CDISC Announces BRIDG Model for Research as Final ISO Standard 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 2Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 3Health News:UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence 4Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 2Health News:Dr. Jeffrey Gosin is Celebrating Three Years at his Somers Point Location! 3
    ... team of German and American researchers have used enetic ... ability to transmit malaria--at least to mice, new study ... the right direction" towards combating malaria in humans, study ... in Ohio. "We now know it is possible to ...
    ... According to researchers, doctors should begin evaluating people's risk ... levels, beginning at age 20, the American Heart Association ... heart attack and stroke. Thomas Pearson, chairman of the ... years,// and there certainly is an opportunity to make ...
    ... chocolate every day is connected to good mood and happy ... has long been seen as a pleasurable indulgence.// However, recent ... contains antioxidants, which can protect from chronic disease. ... who eat chocolate regularly are happier than those who do ...
    ... new study shows some cancer patients who also have ... the drug, interferon.,Past research has suggested a connection between ... //A patient with both of these diseases was treated ... researchers in Paris to study whether the treatment could ...
    ... women with high levels of lead in their bones face ... lead from sources like old pain, researchers reported recently. In ... of lead exposure// “may constitute a significant public health problem, ... bone.” ,The findings demonstrated that protecting children from the ...
    ... with medications can reduce abdominal fat in people with type ... looking into the effect that the drug Pioglitazone has on ... the condition, who took the drug for 16 weeks. ... But measurements revealed an interesting redistribution of body fat, inspite ...
    Cached Medicine News:Health News: Gene researchers make Malaria-resistant mosquito 2Health News:Heart attack risk starts at 20 2
    ... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
    ... The XCell line of mini-cells has ... sturdy and convenient. The tradition continues ... The incorporation of a gel tension ... wedge used on earlier models makes ...
    ... is built upon the success of the ... automates all thermal and wash cycles for ... glass slides. A 4-position GeneMachines Hyb4 ... the individual ports allow for independent probe ...
    Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
    Medicine Products: